Equity · Healthcare
DXCM
NASDAQDexCom (DXCM)
The line runs 87.34 USD on 3 August through 82.30 USD on 30 October, on a scale from 75 to 95. Days the market did not trade hold the previous close, flat.
- Market cap
- 30.7B USD
- P/E (TTM)
- 32.4
- Revenue, year to Dec 2025
- 4.7B USD
- EPS, diluted, year to Dec 2025
- 2.09 USD
- 52-week range
- 54.84 USD – 92.35 USD
- Avg volume
- 249.0K
- Mentions, 30 days
- 3
as of Oct 30, 2026
Have DexCom (DXCM) insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, DexCom insiders reported 12 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 10 Nov 2025.
Form 4, 90 days to 1 Nov 2026, newest reported trade 27 Oct 2026
Buys 0Sells 12Net sold $4.74MOther filings 6
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 27 Oct 2026 | Stern SadieEVP Chief People & Culture Off | Sell | 2,565 | 202K USD |
| 15 Oct 2026 | Brown Michael JonEVP Chief Legal Compliance Off | Sell | 1,700 | 145K USD |
| 28 Sep 2026 | Stern SadieEVP Chief People & Culture Off | Sell | 2,565 | 221K USD |
| 15 Sep 2026 | AUGUSTINOS NICHOLASDirector | Sell | 6,539 | 550K USD |
| 15 Sep 2026 | Brown Michael JonEVP Chief Legal Compliance Off | Sell | 1,700 | 143K USD |
| 14 Sep 2026 | AUGUSTINOS NICHOLASDirector | Sell | 1,550 | 130K USD |
| 10 Sep 2026 | Sylvain Jereme MEVP, Chief Financal Officer | Sell | 3,638 | 303K USD |
| 27 Aug 2026 | Stern SadieEVP Chief People & Culture Off | Sell | 2,565 | 227K USD |
| 20 Aug 2026 | SAYER KEVIN RExecutive Chair | Sell | 26,756 | 2.4M USD |
| 14 Aug 2026 | Brown Michael JonEVP Chief Legal Compliance Off | Sell | 1,700 | 156K USD |
| 12 Aug 2026 | Heller Bridgette PDirector | Sell | 1,012 | 89K USD |
| 03 Aug 2026 | FOLETTA MARK GDirector | Sell | 2,000 | 171K USD |
| Sold | 12 open-market sales | 54,290 | $4.74M |
6 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 10 Sep 2026 | Boehnlein Glenn SDirector | Award | 5,841 | |
| 22 Aug 2026 | Brown Michael JonEVP Chief Legal Compliance Off | Tax withheld | 1,451 | 134K USD |
| 22 Aug 2026 | Stern SadieEVP Chief People & Culture Off | Tax withheld | 1,451 | 134K USD |
| 22 Aug 2026 | Sylvain Jereme MEVP, Chief Financal Officer | Tax withheld | 1,451 | 134K USD |
| 22 Aug 2026 | Leach Jacob StevenPresident, CEO, and Director | Tax withheld | 1,451 | 134K USD |
| 12 Aug 2026 | AUGUSTINOS NICHOLASDirector | Gift | 1,075 |
Which funds hold DexCom (DXCM)?
12 of the 45 institutional funds we track reported a DexCom position for the quarter ended 30 Jun 2026 — a combined 555.8M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 3,237,720 | 218.1M USD | +49.0% |
| Renaissance Technologies | Held (±25%) | 1,630,796 | 109.8M USD | +3.0% |
| Citadel Advisors | Trimmed | 1,211,767 | 81.6M USD | −42.1% |
| Marshall Wace | Added | 532,804 | 35.9M USD | +681.1% |
| Bridgewater Associates | Added | 400,929 | 27.0M USD | +187.0% |
| Millennium Management | Trimmed | 395,392 | 26.6M USD | −75.6% |
| Man Group | Held (±25%) | 394,449 | 26.6M USD | +10.2% |
| Point72 Asset Management | Held (±25%) | 282,840 | 19.0M USD | +9.9% |
| Fisher Asset Management | Trimmed | 61,109 | 4.1M USD | −67.6% |
| GAMCO Investors | Held (±25%) | 52,000 | 3.5M USD | −0.0% |
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Have members of Congress traded DexCom (DXCM)?
The most recent congressional trade disclosed in DexCom is a purchase by Robert P. Bresnahan, Jr. (house, PA), dated 15 May 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 15 May 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 25 days |
| 12 May 2025 | Jefferson Shrevehouse · Republican–IN | Sale | 15K USD–50K USD | 41 days |
| 08 Apr 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 20 days |
| 07 Apr 2025 | Jefferson Shrevehouse · Republican–IN | Sale | 15K USD–50K USD | 31 days |
| 25 Feb 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 30 days |
| 31 Dec 2024 | Kevin Hernhouse · Republican–OK | Sale | 50K USD–100K USD | 15 days |
| 12 Sep 2023 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 33 days |
| 21 Aug 2023 | Josh Gottheimerhouse · Democrat–NJ | Sale | 1K USD–15K USD | 26 days |
What has been filed or recorded for DexCom (DXCM)?
The filings we hold for DexCom, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 09 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 649 shares | 55K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.72 USD | |
| 30 Sep 2026 | Financials | Total assets | 6.2B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 2.5B USD | at period end |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 109,008 shares | 9.7M USD notional · 0.029% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 20,712 shares | 1.9M USD notional · 0.006% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.64 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.51 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 2.09 USD | |
| 31 Dec 2025 | Financials | Revenue | 4.7B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 836.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 2.09 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.70 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.45 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.27 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 1.42 USD |
What is Reddit saying about DexCom (DXCM)?
Reddit mentioned DXCM 3 times in the 30 days to 1 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 1 November 2026.
30-day window, Method
Mentions, 30 days 3Communities 3
How do Reddit mentions of DexCom (DXCM) compare with its price?
Share ↗
Where DexCom (DXCM) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/stocks | 33% | 1 | +0.06 |
| r/investing | 33% | 1 | +0.16 |
| r/wallstreetbets | 33% | 1 | +0.11 |
DexCom (DXCM): frequently asked questions
What did DexCom shares close at?
DexCom closed at 82.30 USD on 30 Oct 2026, up 2.97% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is DexCom’s market cap?
DexCom is worth 30.7B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is DexCom’s P/E ratio?
DexCom has a price-to-earnings ratio of 32.4, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is DexCom’s revenue?
DexCom reported revenue of 4.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have DexCom insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, DexCom insiders reported 12 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 10 Nov 2025. A further 6 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own DexCom?
12 of the 45 funds we track reported a DexCom position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Renaissance Technologies and Citadel Advisors. See Funds
Have members of Congress traded DexCom?
Yes. 15 trades in DexCom appear in the congressional disclosures we hold; the latest is a purchase by Robert P. Bresnahan, Jr. (House, PA) dated 15 May 2025, filed 9 Jun 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did DexCom last report earnings?
DexCom last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.72 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about DexCom?
DexCom was mentioned 0 times in the last 7 days across the finance subreddits we track, and 3 times over the trailing 30 days. Of the 3 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings